Clinical Trial Update: Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating linagliptin's effects on insulin sensitivity and pancreatic beta cell function in patients with Type 2 Diabetes Mellitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tradjenta (Linagliptin)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Type 2 Diabetes Mellitus, Insulin Sensitivity/Resistance | Phase 4 | Status: UNKNOWN